Hepatitis C virus-host interactions: The NS5A protein and the interferon/chemokine systems

Journal of Interferon and Cytokine Research

Volumn 22, Issue 10, 2002, Pages 1005-1012

  Khabar, Khalid S A ^a   Polyak, Stephen J ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE; INTERFERON; INTERLEUKIN 8; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; PROTEIN KINASE R; VIRUS PROTEIN; ALPHA CHEMOKINE; ALPHA INTERFERON; BETA CHEMOKINE; FRACTALKINE; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; RANTES; UNCLASSIFIED DRUG;

DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HOST PARASITE INTERACTION; HUMAN; LIVER DISEASE; METABOLISM; PATHOGENICITY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS REPLICATION; APOPTOSIS; ARTICLE; GENETIC CODE; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TARGET CELL; VIRUS CELL INTERACTION;

ANTIVIRAL AGENTS; CHEMOKINES; EIF-2 KINASE; HEPACIVIRUS; HEPATITIS C; HOST-PARASITE RELATIONS; HUMANS; INTERFERONS; INTERLEUKIN-8; LIVER DISEASES; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0036436838     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999002760624224     Document Type: Article

References (94)

1. Swanton, C., and Jones, N. (2001). Strategies in subversion: De-regulation of the mammalian cell cycle by viral gene products. Int. J. Exp. Pathol. 82, 3-13.
2. Roizman, B. (1999). HSV gene functions: What have we learned that could be generally applicable to its near and distant cousins? Acta Virol. 43, 75-80.
3. Baggiolini, M. (2001). Chemokines in pathology and medicine. J. Intern. Med. 250, 91-104.
4. Burgert, H.G. (1996). Subversion of the MHC class I antigen-presentation pathway by adenoviruses and herpes simplex viruses. Trends Microbiol. 4, 107-112.
5. Lavanchy, D., and McMahon, B. (2000). Worldwide prevalence and prevention of hepatitis C. In: Hepatitis C. T.J. Liang and H.J. Hoofnagle (eds.) San Diego: Academic Press, pp. 185-202.
6. Di Bisceglie, A.M. (1995). Liver transplantation for hepatitis C: The promise and the challenge. Hepatology 22, 660-662.
7. Ferrell, L.D., Wright, T.L., Roberts, J., Ascher, N., and Lake, J. (1992). Hepatitis C viral infection in liver transplant recipients. Hepatology 16, 865-876.
8. Alter, M.J., Kruszon-Moran, D., Nainan, O.V., McQuillan, G.M., Gao, F., Moyer, L.A., Kaslow, R.A., and Margolis, H.S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341, 556-562.
9. Wasley, A., and Alter, M.J. (2000). Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin. Liver Dis. 20, 1-16.
10. Bellentani, S., Miglioli, L., Masutti, F., Saccoccio, G., and Tiribelli, C. (2000). Epidemiology of hepatitis C virus infection in Italy: The slowly unraveling mystery. Microbes Infect. 2, 1757-1763.
11. Zein, N.N. (2000). Clinical significance of hepatitis C virus genotypes. Clin. Microbiol. Rev. 13, 223-235.
12. Lindsay, K.L. (1997). Therapy of hepatitis C: Overview. Hepatology 26, 71S-77S.
13. Davis, G.L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S.C., Trepo, C., Shiffman, M.L., Zeuzem, S., Craxi, A., Ling, M.H., and Albrecht, J. (1998). Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N. Engl. J. Med. 339, 14931499.
14. McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodman, Z.D., Ling, M.H., Cort, S., and Albrecht, J.K. (1998). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339, 1485-1492.
15. Poynard, T., Marcellin, P., Lee, S.S., Niederau, C., Minuk, G.S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., and Albrecht, J. (1998). Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group. Lancet 352, 1426-1432.
16. Lindsay, K.L., Trepo, C., Heintges, T., Shiffman, M.L., Gordon, S.C., Hoefs, J.C., Schiff, E.R., Goodman, Z.D., Laughlin, M., Yao, R., and Albrecht, J.K. (2001). A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34, 395-403.
17. Reddy, K.R., Wright, T.L., Pockros, P.J., Shiffman, M., Everson, G., Reindollar, R., Fried, M.W., Purdum, P.P., 3rd, Jensen, D., Smith, C., Lee, W.M., Boyer, T.D., Lin, A., Pedder, S., and DePamphilis, J. (2001). Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology 33, 433-438.
18. Glue, P., Rouzier-Panis, R., Raffanel, C., Sabo, R., Gupta, S.K., Salfi, M., Jacobs, S., and Clement, R.P. (2000). A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. Hepatology 32, 647-653.
19. Walewski, J.L., Keller, T.R., Stump, D.D., and Branch, A.D. (2001). Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7, 710-721.
20. Purcell, R. (1997). The hepatitis C virus: Overview. Hepatology 26, 11S-14S.
21. Nousbaum, J.-B., Polyak, S.J., Sullivan, D.G., Larson, A.M., Carithers, R.L., Jr., and Gretch, D.R. (2000). Prospective characterization of full-length HCV NS5A quasi-species during induction and combination antiviral therapy. J. Virol. 74, 9028-9038.
22. Blight, K.J., Kolykhalov, A.A., and Rice, C.M. (2000). Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972-1974.
23. Qin, W., Yamashita, T., Shirota, Y., Lin, Y., Wei, W., and Murakami, S. (2001). Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase. Hepatology 33, 728-737.
24. Shirota, Y., Luo, H., Qin, W., Kaneko, S., Yamashita, T., Kobayashi, K., and Murakami, S. (2002). Hepatitis C virus NS5A binds RNA-dependent RNA polymerase NS5B and modulates RdRP activity. J. Biol. Chem. 277, 11149-11155.
25. Lohmann, V., Korner, F., Dobierzewska, A., and Bartenschlager, R. (2001). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75, 1437-1449.
26. Krieger, N., Lohmann, V., and Bartenschlager, R. (2001). Enhancement of hepatitis c virus RNA replication by cell culture - Adaptive mutations. J. Virol. 75, 4614-4624.
27. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F., and Sato, C. (1996). Mutations in the nonstructural protein 5A and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334, 77-81.
28. Thomson, M., Nascimbeni, M., Gonzales, S., Murthy, K.K., Rehermann, B., and Liang, T.J. (2001). Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. Gastroenterology 121, 1226-1233.
29. Tan, S.L., Nakao, H., He, Y.P., Vijaysri, S., Neddermann, P., Jacobs, B.L., Mayer, B.J., and Katze, M.G. (1999). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc. Natl. Acad. Sci. USA 96, 5533-5538.
30. He, Y., Tan, S.L., Tareen, S.U., Vijaysri, S., Langland, J.O., Jacobs, B.L., and Katze, M.G. (2001). Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J. Virol. 75, 5090-5098.
31. Gale, M., Kwieciszewski, B., Dossett, M., Nakao, H., and Katze, M.G. (1999). Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73, 6506-6516.
32. Ghosh, A.K., Majumder, M., Steele, R., Meyer, K., Ray, R., and Ray, R.B. (2000). Hepatitis C virus NSSA protein protects against TNF-alpha mediated apoptotic cell death. Virus Res. 67, 173-178.
33. Ezelle, H.J., Balachandran, S., Sicheri, F., Polyak, S.J., and Barber, G.N. (2001). Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A. Virology 281, 124-137.
34. Park, K.J., Choi, S.H., Lee, S.Y., Hwang, S.B., and Lai, M.M. (2002). Nonstructural 5A protein of hepatitis C virus modulates TNF-alpha-stimulated NF-kappa B activation. J. Biol. Chem. 277, 13122-13128.
35. Gong, G., Waris, G., Tanveer, R., and Siddiqui, A. (2001). Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. USA 98, 9599-9604.
36. Arima, N., Kao, C.Y., Licht, T., Padmanabhan, R., and Sasaguri, Y. (2001). Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J. Biol. Chem. 276, 12675-12684.
37. Satoh, S., Hirota, M., Noguchi, T., Hijikata, M., Handa, H., and Shimotohno, K. (2000). Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. Virology 270, 476-487.
38. Shi, S.T., Polyak, S.J., Hong, T., Taylor, D.R., Gretch, D.R., and Lai, M.M.C. (2002). Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292, 198-210.
39. Darnell, J.E., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
40. Khabar, K.S.A., Dhalla, M., Siddiqui, Y., Zhou, A., Alahdal, M.N., Der, S.D., Silverman, R.H., and Williams, B.R. (2000). Effect of the deficiency of the double-stranded RNA dependent protein kinase, PKR, on antiviral resistance in presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20, 653-659.
41. Zhou, A., Paranjape, J., Brown, T.L., Nie, H., Naik, S., Dong, B., Chang, A., Trapp, B., Fairchild, R., Colmenares, C., and Silverman, R.H. (1997). Interferon action and apoptosis are defective in mice devoid of 2′, 5′-oligoadenylate-dependent RNase L. EMBO J. 16, 6355-6363.
42. Zhou, A., Paranjape, J.M., Der, S.D., Williams, B.R., and Silverman, R.H. (1999). Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258, 435-440.
43. Silverman, R.H. (1997). 2-5A-dependent RNAse L: A regulated endoribonuclease in the interferon system. In: Ribonucleases: Structure and Function. G. D'Alessio and J.F. Riordan (eds.) New York: Academic Press, pp. 515-551.
44. Silverman, R.H., and Williams, B.R. (1999). Translational control perks up. Nature 397, 208-209, 211.
45. Meurs, E., Chong, K., Galabru, J., Thomas, N.S., Kerr, I.M., Willliams, B.R.G., and Hovanessian, A.G. (1990). Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390.
46. Meurs, E.F., Watanabe, Y., Kadereit, S., Barber, G.N., Katze, M.G., Chong, K., Williams, B.R., and Hovanessian, A.G. (1992). Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66, 5804-5814.
47. Pavlovic, J., Zurcher, T., Haller, O., and Staeheli, P. (1990). Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64, 3370-3375.
48. Samuel, C.E. (2001). Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809.
49. Heim, M.H., Moradpour, D., and Blum, H.E. (1999). Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73, 8469-8475.
50. Polyak, S.J., Paschal, D., McArdle, S., Gale, M., Moradpour, D., and Gretch, D.R. (1999). Characterization of the effects of hepatitis C virus non-structural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 29, 1262-1271.
51. Francois, C., Duverlie, G., Rebouillat, D., Khorsi, H., Castelain, S., Blum, H.E., Gatignol, A., Wychowski, C., Moradpour, D., and Meurs, E.F. (2000). Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74, 5587-5596.
52. Paterson, M., Laxton, C.D., Thomas, H.C., Ackrill, A.M., and Foster, G.R. (1999). Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology 117, 1187-1197.
53. Song, J., Fujii, M., Wang, F., Itoh, M., and Hotta, H. (1999). The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J. Gen. Virol. 80, 879-886.
54. Aizaki, H., Saito, S., Ogino, T., Miyajima, N., Harada, T., Matsuura, Y., Miyamura, T., and Kohase, M. (2000). Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins. J. Interferon Cytokine Res. 20, 1111-1120.
55. Gale, M.J., Korth, M.J., Tang, N.M., Tan, S.L., Hopkins, D.A., Dever, T.E., Polyak, S.J., Gretch, D.R., and Katze, M.G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227.
56. Gale, M., Blakely, C.M., Kwieciszewski, B., Tan, S.L., Dossett, M., Tang, N.M., Korth, M.J., Polyak, S.J., Gretch, D.R., and Katze, M.G. (1998). Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18, 5208-5218.
57. Polyak, S.J., Khabar, K.S., Paschal, D.M., Ezelle, H.J., Duverlie, G., Barber, G.N., Levy, D.E., Mukaida, N., and Gretch, D.R. (2001). Hepatitis C virus nonstructural 5A protein induces intefieukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75, 6095-6106.
58. Girard, S., Shalhoub, P., Lescure, P., Sabile, A., Misek, D.E., Hanash, S., Brechot, C., and Beretta, L. (2002). An Altered cellular response to interferon and up-regulation of interleukin-8 induced by hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295, 272-283.
59. Ben-Baruch, A., Michiel, D.F., and Oppenheim, J.J. (1995). Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270, 11703-11706.
60. Howard, O.M., Oppenheim, J.J., and Wang, J.M. (1999). Chemokines as molecular targets for therapeutic intervention. J. Clin. Immunol. 19, 280-292.
61. Rosenkilde, M.M., Waldhoer, M., Luttichau, H.R., and Schwartz, T.W. (2001). Virally encoded 7TM receptors. Oncogene 20, 1582-1593.
62. Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N., and Yamanishi, K. (1998). Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol. 72, 6104-6112.
63. Gao, J.L., and Murphy, P.M. (1994). Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem. 269, 28539-28542.
64. Kuhn, D.E., Beall, C.J., and Kolattukudy, P.E. (1995). The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem. Biophys. Res. Commun. 211, 325-330.
65. Casarosa, P., Bakker, R.A., Verzijl, D., Navis, M., Timmerman, H., Leurs, R., and Smit, M.J. (2001). Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J. Biol. Chem. 276, 1133-1137.
66. Guo, H.G., Browning, P., Nicholas, J., Hayward, G.S., Tschachler, E., Jiang, Y.W., Sadowska, M., Raffeld, M., Colombini, S., Gallo, R.C., and Reitz, M.S., Jr. (1997). Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology 228, 371-378.
67. Kirshner, J.R., Staskus, K., Haase, A., Lagunoff, M., and Ganem, D. (1999). Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: Implications for KS pathogenesis. J. Virol. 73, 6006-6014.
68. Cowley, S. (2001). The biology of HIV infection. Lepr. Rev. 72, 212-220.
69. Khabar, K.S., Murayama, T., Al-Ahdal, M.N., Mukaida, N., and Matsushima, K. (2000). Interleukin-8 Is Induced by Viruses, Enhances Cytomegalovirus and Picornavirus Replication, and Inhibits the Antiviral Action of Interferon-Alpha. Enfield, NH: Science Publishers, Inc.
70. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H.F., Leonard, E.J., and Oppenheim, J.J. (1988). Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1883-1893.
71. Choi, A.M., and Jacoby, D.B. (1992). Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett. 309, 327-329.
72. Fiedler, M.A., Wernke-Dollries, K., and Stark, J.M. (1995). Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269, L865-872.
73. Polyak, S.J., Khabar, K.S., Rezeiq, M., and Gretch, D.R. (2001). Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J. Virol. 75, 6209-6211.
74. Domachowske, J.B., Bonville, C.A., and Rosenberg, H.F. (2001). Gene expression in epithelial cells in response to pneumovirus infection. Respir. Res. 2, 225-233.
75. Sheth, R., Anderson, J., Sato, T., Oh, B., Hempson, S.J., Rollo, E., Mackow, E.R., and Shaw, R.D. (1996). Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology 221, 251-259.
76. Leland Booth, J., and Metcalf, J.P. (1999). Type-specific induction of interleukin-8 by adenovirus. Am. J. Respir. Cell Mol. Biol. 21, 521-527.
77. Murayama, T., Ohara, Y., Obuchi, M., Khabar, K.S., Higashi, H., Mukaida, N., and Matsushima, K. (1997). Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene. J. Virol. 71, 5692-5695.
78. Fiedler, M.A., Wernke-Dollries, K., and Stark, J.M. (1996). Mechanism of RSV-induced IL-8 gene expression in A549 cells before viral replication. Am. J. Physiol. 271, L963-971.
79. Konig, B., Krusat, T., Streckert, H.J., and Konig, W. (1996). IL-8 release from human neutrophils by the respiratory syncytial virus is independent of viral replication. J. Leukocyte Biol. 60, 253-260.
80. Murayama, T., Mukaida, N., Sadanari, H., Yamaguchi, N., Khabar, K.S., Tanaka, J., Matsushima, K., Mori, S., and Eizuru, Y. (2000). The immediate-early gene 1 product of human cytomegalovirus is sufficient for up-regulation of intedeukin-8 gene expression. Biochem. Biophys. Res. Commun. 279, 298-304.
81. Yoshizaki, T., Horikawa, T., Qing-Chun, R., Wakisaka, N., Takeshita, H., Sheen, T.S., Lee, S.Y., Sato, H., and Furukawa, M. (2001). Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin. Cancer Res. 7, 1946-1951.
82. Murayama, T., Mukaida, N., Khabar, K.S., and Matsushima, K. (1998). Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. J. Leukocyte Biol. 64, 62-67.
83. Roux, P., Alfieri, C., Hrimech, M., Cohen, E.A., and Tanner, J.E. (2000). Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 74, 4658-4665.
84. Shaw, G., and Kamen, R. (1986). A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
85. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C.Y., Shyu, A.B., Muller, M., Gaestel, M., Resch, K., and Holtmann, H. (1999). The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18, 4969-4980.
86. Bakheet, T., Frevel, M., Williams, B.R.G., Greer, W., and Khabar, K.S.A. (2001). ARED: Human AU-rich elementcontaining mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 29, 246-254.
87. Khabar, K.S., Al-Zoghaibi, F., Al-Ahdal, M.N., Murayama, T., Dhalla, M., Mukaida, N., Taha, M., Al-Sedairy, S.T., Siddiqui, Y., Kessie, G., and Matsushima, K. (1997). The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 186, 1077-1085.
88. Murayama, T., Kuno, K., Jisaki, F., Obuchi, M., Sakamuro, D., Furukawa, T., Mukaida, N., and Matsushima, K. (1994). Enhancement of human cytomegalovims replication in a human lung fibroblast cell line by interleukin-8. J. Virol. 68, 7582-7585.
89. Lane, B.R., Lore, K., Bock, P.J., Andersson, J., Coffey, M.J., Strieter, R.M., and Markovitz, D.M. (2001). Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J. Virol. 75, 8195-8202.
90. Bernier, J., Reuter, A., Vrindts-Gevaert, Y., and Franchimont, P. (1984). Radioimmunoassay of leukocyte (alpha) interferon and its application to some clinical conditions. J. Nucl. Med. 25, 765-772.
91. Bornemann, L.D., Spiegel, H.E., Dziewanowska, Z.E., Krown, S.E., and Colburn, W.A. (1985). Intravenous and intramuscular pharmacokinetics of recombinant leukocyte A interferon. Eur. J. Clin. Pharmacol. 28, 469-471.
92. Johnston, S.L. (1995). Natural and experimental rhinovirus infections of the lower respiratory tract. Am. J. Respir. Crit. Care Med. 152, S46-52.
93. Matsumoto, T., Miike, T., Nelson, R.P., Trudeau, W.L., Lockey, R.F., and Yodoi, J. (1993). Elevated serum levels of IL-8 in patients with HIV infection. Clin. Exp. Immunol. 93, 149-151.
94. Khabar, K.S., Al-Zoghaibi, F., Murayama, T., Matsushima, K., Mukaida, N., Siddiqui, Y., Dhalla, M., and Al-Ahdal, M.N. (1997). Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochem. Biophys. Res. Commun. 235, 774-778.